Clinical significance of serum S100 in metastatic malignant melanoma

By Guo H.B.   Stoffel-Wagner B.   Bierwirth T.   Mezger J.   Klingmuller D.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 924-928

Elsevier

Access to resources Recommend Favorite

Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma

By Banfalvi T.   Gilde K.   Gergye M.   Boldizsar M.   Kremmer T.   Otto S.  

European Journal of Cancer, Vol. 39, Iss. 2, 2003-01 ,pp. : 164-169

Elsevier

Access to resources Recommend Favorite

Clinical Activity of Celecoxib in Metastatic Malignant Melanoma

By Wilson Kenneth  

Cancer Investigation, Vol. 24, Iss. 8, 2006-10 ,pp. : 740-746

Informa Healthcare

Access to resources Recommend Favorite

Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma

By Mohammed M.Q.   Abraha H.D.   Sherwood R.A.   MacRae K.   Retsas S.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 109-120

Humana Press, Inc

Access to resources Recommend Favorite

Metastatic Patterns, Clinical Outcome, and Malignant Phenotype in Malignant Cutaneous Melanoma

By Cohn-Cedermark Gabriella   Månsson-Brahme Eva   Rutqvist Lars Erik   Larsson Olle   Singnomklao Toom   Ringborg Ulrik  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 549-558

Informa Healthcare

Access to resources Recommend Favorite